Asmaa Boudribila

Asmaa Boudribila has over 17 years of work experience in the medical field. From 2004 to 2009, they worked as an Intern at AP-HP. In 2006, they began working as a Medical Research Clinician at ABR PHARMA (CRO), where they were responsible for the setup, monitoring, and closure of phase III and IV clinical studies on various therapeutic areas. From 2008 to 2011, they worked as a Pharmacovigilance Physician at For Drug Consulting. From 2011 to 2013, they were an MSL at AbbVie, and from 2013 to 2014, they were an International Trial Physician HCV at Janssen R&D. From 2017 to 2022, they have held roles as a Clinical Development Physician at PIERRE FABRE MEDICAMENT PRODUCTION and Senior Clinical Project Manager at ERT. Currently, they are a Medical Director at DOMAIN Therapeutics.

Asmaa Boudribila obtained their Doctorate in General Medicine from Faculté de Médecine in 2004. Asmaa then pursued a DIU FIEC in Research Clinical from Paris in 2008-2009. From 2007-2008, they obtained a DU in Geriatrics and Renal Pathology from Université Paris VII, Diderot. Asmaa also completed a Certificate in Nephrology from Universite de Paris V from 2006-2008.